Correction to Lancet Digit Health 2023; 5: e404–20

Saad MB, Hong L, Aminu M, et al. Predicting benefit from immune checkpoint inhibitors in patients with non-small-cell lung cancer by CT-based ensemble deep learning: a retrospective study. Lancet Digit Health 2023; 5: e404–20—In figure 4A of this Article, the footnotes for the p values from the analysis of bone metastasis and for the analysis of number of metastatic organs in the discovery cohort have been corrected. Additionally, in figure 6B, the p values for the validation cohort have been corrected. Statistical significance remains unchanged for each of the corrected p values. In the second paragraph of the Study design and participants section, “or anti-CTLA-4 inhibitors” has been removed from point 3. In the last sentence of the Model construction section, “Cox regression” has been corrected to “random survival forests”. The MD Anderson Cancer Centre Support grant number should have been P30 CA016672. These corrections have been made as of June 28, 2023.